Treatment of penicillin-resistant staphylococcal infections with clindamycin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004917:Erythromycin / Q000494:pharmacology; D005667:Furunculosis / Q000188:drug therapy; D006027:Glycosides / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007169:Impetigo / Q000188:drug therapy; D007223:Infant; D008034:Lincomycin / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D011759:Pyrrolidines / Q000494:pharmacology / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D006027:Glycosides; D010406:Penicillins; D011759:Pyrrolidines; D004917:Erythromycin; D008034:Lincomycin; D013752:Tetracycline